alprazolam has been researched along with Breast Cancer in 4 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alprazolam, a newer benzodiazepine, may be useful in the control of nausea and vomiting in breast cancer patients." | 9.11 | Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer. ( Abali, H; Guler, N; Oyan, B, 2005) |
| "We studied tropisetron (T) in patients with breast cancer receiving standard adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil) over 3 consecutive cycles; T was administered alone or in combination with dexamethasone (D) or alprazolam (A)." | 9.09 | Comparative study of tropisetron with the addition of dexamethasone or alprazolam in breast cancer patients receiving adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil). ( Agelopoulou, A; Boulamatsis, D; Kontos, A; Kosmas, C; Koufos, C; Sougioultzis, S; Tsavaris, N; Vadiaka, M, 2001) |
| "The adjunct of alprazolam to a psychologic support program delays the occurrence of anticipatory nausea and controls sleeping problems secondary to adjunct CT." | 9.07 | Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. ( Beauduin, M; De Brier, F; Delvaux, N; Derde, MP; Farvacques, C; Kaufman, L; Piccart, M; Razavi, D; Van Heer, C, 1993) |
| "Alprazolam, a newer benzodiazepine, may be useful in the control of nausea and vomiting in breast cancer patients." | 5.11 | Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer. ( Abali, H; Guler, N; Oyan, B, 2005) |
| "We studied tropisetron (T) in patients with breast cancer receiving standard adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil) over 3 consecutive cycles; T was administered alone or in combination with dexamethasone (D) or alprazolam (A)." | 5.09 | Comparative study of tropisetron with the addition of dexamethasone or alprazolam in breast cancer patients receiving adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil). ( Agelopoulou, A; Boulamatsis, D; Kontos, A; Kosmas, C; Koufos, C; Sougioultzis, S; Tsavaris, N; Vadiaka, M, 2001) |
| "The adjunct of alprazolam to a psychologic support program delays the occurrence of anticipatory nausea and controls sleeping problems secondary to adjunct CT." | 5.07 | Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam. ( Beauduin, M; De Brier, F; Delvaux, N; Derde, MP; Farvacques, C; Kaufman, L; Piccart, M; Razavi, D; Van Heer, C, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abali, H | 1 |
| Oyan, B | 1 |
| Guler, N | 1 |
| Razavi, D | 1 |
| Delvaux, N | 1 |
| Farvacques, C | 1 |
| De Brier, F | 1 |
| Van Heer, C | 1 |
| Kaufman, L | 1 |
| Derde, MP | 1 |
| Beauduin, M | 1 |
| Piccart, M | 1 |
| Tsavaris, N | 1 |
| Kosmas, C | 1 |
| Vadiaka, M | 1 |
| Sougioultzis, S | 1 |
| Kontos, A | 1 |
| Agelopoulou, A | 1 |
| Boulamatsis, D | 1 |
| Koufos, C | 1 |
| Tamaki, K | 1 |
| Nishida, M | 1 |
| Hiraide, H | 1 |
| Tamakuma, S | 1 |
3 trials available for alprazolam and Breast Cancer
| Article | Year |
|---|---|
Alprazolam significantly improves the efficacy of granisetron in the prophylaxis of emesis secondary to moderately emetogenic chemotherapy in patients with breast cancer.
Topics: Alprazolam; Anthracyclines; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neop | 2005 |
Prevention of adjustment disorders and anticipatory nausea secondary to adjuvant chemotherapy: a double-blind, placebo-controlled study assessing the usefulness of alprazolam.
Topics: Adjustment Disorders; Adult; Aged; Alprazolam; Anxiety; Breast Neoplasms; Chemotherapy, Adjuvant; De | 1993 |
Comparative study of tropisetron with the addition of dexamethasone or alprazolam in breast cancer patients receiving adjuvant chemotherapy with CEF (cyclophosphamide, epirubicin and 5-fluorouracil).
Topics: Adult; Alprazolam; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cy | 2001 |
1 other study available for alprazolam and Breast Cancer
| Article | Year |
|---|---|
[Alprazolam for patients with psychotic symptoms or autonomic imbalance symptoms after breast cancer surgery].
Topics: Adult; Aged; Alprazolam; Autonomic Nervous System Diseases; Breast Neoplasms; Female; Humans; Mastec | 1991 |